Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Circulating miRNA-181b-5p, miRNA-223-3p, miRNA-210-3p, let 7i-5p, miRNA-21-5p and miRNA-29a-3p in patients with localized scleroderma as potential biomarkers

19 Nov 2020

Abstract excerpt

Localized scleroderma (LoSc) is a rare disease manifested by an inflammation and sclerosis of the skin. The latest studies focused on glycoprotein Krebs von den Lungen-6, surfactant protein-D, chemokine ligand 18 and dipeptidylpeptidase 4 as potential biomarkers of skin fibrosis in systemic scleroderma. Our study aimed to identify 6 miRNAs with elevated or decreased levels in 38 LoSc patients (31 females, 7...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related molecular mechanisms research
Share to MicroRNA in disease regulation
Share to Systemic Sclerosis and Related Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33214624
DOI: 10.1038/s41598-020-76995-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Circulating miRNA-181b-5p, miRNA-223-3p, miRNA-210-3p, let 7i-5p, miRNA-21-5p and miRNA-29a-3p in patients with localized scleroderma as potential biomarkersPMID 33214624Read ↗

MicroRNA in localized scleroderma: a review of literatureSemantic proximity Read ↗

MicroRNAs in Systemic Sclerosis: Involvement in Disease Pathogenesis and Potential Use as Diagnostic Biomarkers and Therapeutic TargetsSemantic proximity Read ↗

MicroRNAs: their involvement in fibrosis pathogenesis and use as diagnostic biomarkers in sclerodermaSemantic proximity Read ↗

MiR-27a as a diagnostic biomarker and potential therapeutic target in systemic sclerosisSemantic proximity Read ↗

Critical roles of microRNAs in the pathogenesis of systemic sclerosis: New advances, challenges and potential directionsSemantic proximity Read ↗

Differentially Regulated miRNAs and Their Related Molecular Pathways in Lichen SclerosusSemantic proximity Read ↗

Serum microRNA screening and functional studies reveal miR-483-5p as a potential driver of fibrosis in systemic sclerosisSemantic proximity Read ↗

Novel Concepts in Systemic Sclerosis Pathogenesis: Role for miRNAsSemantic proximity Read ↗

The Downregulation of microRNA let-7a Contributes to the Excessive Expression of Type I Collagen in Systemic and Localized SclerodermaSemantic proximity Read ↗

Role of microRNA in the pathogenesis of systemic sclerosis tissue fibrosis and vasculopathySemantic proximity Read ↗

Identification of lncRNA–miRNA–mRNA networks in circulating exosomes as potential biomarkers for systemic sclerosisSemantic proximity Read ↗

Molecular and Genetic Biomarkers in Idiopathic Pulmonary Fibrosis: Where Are We Now?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.